Natixis Investment Managers International Johnson & Johnson Transaction History

Natixis Investment Managers International

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$145.6 - $158.88 $115,024 - $125,515	790 Added 0.63%	126,900 $19.9 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $5.9 Million - $6.61 Million	-37,880 Reduced 23.1%	126,110 $19.6 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $1.78 Million - $1.92 Million	-11,550 Reduced 6.58%	163,990 $27.1 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $1.39 Million - $1.65 Million	9,170 Added 5.51%	175,540 $27.2 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $27.7 Million - $30.8 Million	-171,503 Reduced 50.76%	166,370 $27.2 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $4.79 Million - $5.3 Million	-28,470 Reduced 7.77%	337,873 $60 Million
Q1 2022 May 13, 2022	BUY	$158.14 - $179.59 $57.9 Million - $65.8 Million	366,343 New	366,343 $64.9 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $4.16 Million - $5 Million	-33,848 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $1.14 Million - $1.34 Million	9,392 Added 38.4%	33,848 $4.68 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $319,514 - $352,589	2,676 Added 12.29%	24,456 $2.97 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $2.72 Million - $3.23 Million	21,780 New	21,780 $2.79 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $2.24 Million - $2.45 Million	-17,061 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $1.15 Million - $1.2 Million	-8,900 Reduced 34.28%	17,061 $2.22 Million
Q2 2017 Aug 14, 2017	BUY	N/A	25,961	25,961 $3.44 Million

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

Stay updated on Natixis Investment Managers International with notifications on news.